|
1
|
The gelatin sponge-chorioallantoic membrane assay.
|
Nat Protoc
|
2006
|
1.77
|
|
2
|
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
|
Cancer Res
|
2006
|
1.72
|
|
3
|
Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer.
|
Am J Obstet Gynecol
|
2005
|
1.69
|
|
4
|
The role of pericytes in angiogenesis.
|
Int J Dev Biol
|
2011
|
1.42
|
|
5
|
Endothelial cell heterogeneity and organ specificity.
|
J Hematother Stem Cell Res
|
2002
|
1.35
|
|
6
|
Effect of bortezomib on human neuroblastoma cell growth, apoptosis, and angiogenesis.
|
J Natl Cancer Inst
|
2006
|
1.32
|
|
7
|
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis.
|
J Anat
|
2004
|
1.22
|
|
8
|
Docetaxel versus paclitaxel for antiangiogenesis.
|
J Hematother Stem Cell Res
|
2002
|
1.16
|
|
9
|
Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4.
|
FASEB J
|
2004
|
1.16
|
|
10
|
Endothelial cells in the bone marrow of patients with multiple myeloma.
|
Blood
|
2003
|
1.15
|
|
11
|
Enhanced antitumor efficacy of clinical-grade vasculature-targeted liposomal doxorubicin.
|
Clin Cancer Res
|
2008
|
1.14
|
|
12
|
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma.
|
Cancer Treat Rev
|
2006
|
1.10
|
|
13
|
A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice.
|
Am J Pathol
|
2005
|
1.10
|
|
14
|
Piecemeal degranulation as a general secretory mechanism?
|
Anat Rec A Discov Mol Cell Evol Biol
|
2003
|
1.09
|
|
15
|
Mast cells and angiogenesis in gastric carcinoma.
|
Int J Exp Pathol
|
2010
|
1.09
|
|
16
|
Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis.
|
Clin Cancer Res
|
2007
|
1.05
|
|
17
|
Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
|
J Clin Oncol
|
2005
|
1.05
|
|
18
|
Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis.
|
Cancer Lett
|
2008
|
1.04
|
|
19
|
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle.
|
Neurobiol Dis
|
2008
|
1.03
|
|
20
|
Morphological and molecular aspects of physiological vascular morphogenesis.
|
Angiogenesis
|
2009
|
1.02
|
|
21
|
The role of adrenomedullin in angiogenesis.
|
Peptides
|
2005
|
1.02
|
|
22
|
Angiogenesis in neuroblastoma.
|
Ann N Y Acad Sci
|
2004
|
1.02
|
|
23
|
Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis.
|
J Immunol
|
2003
|
1.00
|
|
24
|
Role of mitochondria and reactive oxygen species in dendritic cell differentiation and functions.
|
Free Radic Biol Med
|
2008
|
1.00
|
|
25
|
Neovascularization and mast cells with tryptase activity increase simultaneously in human pterygium.
|
J Cell Mol Med
|
2007
|
0.99
|
|
26
|
Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay.
|
Int J Dev Biol
|
2011
|
0.98
|
|
27
|
Leptin-leptin receptor are involved in angiogenesis in human hepatocellular carcinoma.
|
Peptides
|
2008
|
0.97
|
|
28
|
Enalapril treatment discloses an early role of angiotensin II in inflammation- and oxidative stress-related muscle damage in dystrophic mdx mice.
|
Pharmacol Res
|
2011
|
0.96
|
|
29
|
Mitochondrial defect and PGC-1α dysfunction in parkin-associated familial Parkinson's disease.
|
Biochim Biophys Acta
|
2011
|
0.96
|
|
30
|
Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
|
J Control Release
|
2010
|
0.96
|
|
31
|
The combined therapeutic effects of bortezomib and fenretinide on neuroblastoma cells involve endoplasmic reticulum stress response.
|
Clin Cancer Res
|
2009
|
0.95
|
|
32
|
The structure of the vascular network of tumors.
|
Cancer Lett
|
2006
|
0.95
|
|
33
|
Hematopoietic cancer and angiogenesis.
|
Stem Cells Dev
|
2004
|
0.94
|
|
34
|
Development of the blood-brain barrier: a historical point of view.
|
Anat Rec B New Anat
|
2006
|
0.94
|
|
35
|
Synergistic inhibition of human neuroblastoma-related angiogenesis by vinblastine and rapamycin.
|
Oncogene
|
2005
|
0.93
|
|
36
|
In vivo angiogenic activity of neuroblastoma correlates with MYCN oncogene overexpression.
|
Int J Cancer
|
2002
|
0.93
|
|
37
|
Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
|
Mol Cancer Ther
|
2005
|
0.93
|
|
38
|
Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.
|
J Immunol
|
2006
|
0.93
|
|
39
|
The role of angiogenesis in human non-Hodgkin lymphomas.
|
Neoplasia
|
2013
|
0.92
|
|
40
|
First evaluation of the potential effectiveness in muscular dystrophy of a novel chimeric compound, BN 82270, acting as calpain-inhibitor and anti-oxidant.
|
Neuromuscul Disord
|
2006
|
0.92
|
|
41
|
Angiogenic response induced by acellular brain scaffolds grafted onto the chick embryo chorioallantoic membrane.
|
Brain Res
|
2003
|
0.92
|
|
42
|
Beta amyloid angiogenic activity in vitro and in vivo.
|
Int J Mol Med
|
2007
|
0.91
|
|
43
|
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
|
Clin Cancer Res
|
2013
|
0.91
|
|
44
|
The chromaffin vesicle: advances in understanding the composition of a versatile, multifunctional secretory organelle.
|
Anat Rec (Hoboken)
|
2008
|
0.88
|
|
45
|
An active mitochondrial biogenesis occurs during dendritic cell differentiation.
|
Int J Biochem Cell Biol
|
2012
|
0.87
|
|
46
|
HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
|
Clin Cancer Res
|
2013
|
0.87
|
|
47
|
Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma.
|
Oncol Rep
|
2005
|
0.86
|
|
48
|
An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.
|
Cancer Lett
|
2009
|
0.85
|
|
49
|
In vitro and in vivo evaluation of acellular diaphragmatic matrices seeded with muscle precursors cells and coated with VEGF silica gels to repair muscle defect of the diaphragm.
|
J Biomed Mater Res A
|
2009
|
0.85
|
|
50
|
Ghrelin inhibits FGF-2-mediated angiogenesis in vitro and in vivo.
|
Peptides
|
2004
|
0.85
|
|
51
|
Tryptase-positive mast cells and CD8-positive T cells in human endometrial cancer.
|
Pathol Int
|
2011
|
0.84
|
|
52
|
Mast cell contribution to tumor angiogenesis: a clinical approach.
|
Eur Cytokine Netw
|
2009
|
0.84
|
|
53
|
Effects on in vitro and in vivo angiogenesis induced by small peptides carrying adhesion sequences.
|
J Pept Sci
|
2010
|
0.84
|
|
54
|
Tumoral mast cells exhibit a common spatial distribution.
|
Cancer Lett
|
2008
|
0.84
|
|
55
|
In vitro and in vivo proposal of an artificial esophagus.
|
J Biomed Mater Res A
|
2006
|
0.84
|
|
56
|
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
|
Mol Cancer Ther
|
2012
|
0.84
|
|
57
|
Angiogenic response induced by acellular aortic matrix in vivo.
|
Anat Rec A Discov Mol Cell Evol Biol
|
2004
|
0.83
|
|
58
|
Chromaffin granules in the rat adrenal medulla release their secretory content in a particulate fashion.
|
Anat Rec A Discov Mol Cell Evol Biol
|
2004
|
0.83
|
|
59
|
An image analysis of the spatial distribution of perivascular mast cells in human melanoma.
|
Int J Mol Med
|
2006
|
0.83
|
|
60
|
Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro.
|
Int J Mol Med
|
2006
|
0.83
|
|
61
|
In vivo time-course of the angiogenic response induced by multiple myeloma plasma cells in the chick embryo chorioallantoic membrane.
|
J Anat
|
2003
|
0.82
|
|
62
|
Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo.
|
Oncogene
|
2003
|
0.82
|
|
63
|
VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex.
|
BMC Neurosci
|
2011
|
0.82
|
|
64
|
B-cell non-Hodgkin's lymphomas express heterogeneous patterns of neovascularization.
|
Haematologica
|
2003
|
0.81
|
|
65
|
Immunotherapy of neuroblastoma by an Interleukin-21-secreting cell vaccine involves survivin as antigen.
|
Cancer Immunol Immunother
|
2008
|
0.81
|
|
66
|
Angiogenesis: basic and clinical aspects.
|
Ital J Anat Embryol
|
2003
|
0.81
|
|
67
|
The history of the controversial relationship between mast cells and basophils.
|
Immunol Lett
|
2011
|
0.80
|
|
68
|
Ultrastructural morphology of adrenal chromaffin cells indicative of a process of piecemeal degranulation.
|
Anat Rec A Discov Mol Cell Evol Biol
|
2003
|
0.80
|
|
69
|
Ultrastructural analysis of mast cell recovery after secretion by piecemeal degranulation in B-cell non-Hodgkin's lymphoma.
|
Leuk Lymphoma
|
2003
|
0.80
|
|
70
|
Angiogenic activity of rat mast cells in the chick embryo chorioallantoic membrane is down-regulated by treatment with recombinant human alpha-2a interferon and partly mediated by fibroblast growth factor-2.
|
Haematologica
|
2002
|
0.80
|
|
71
|
Fenretinide as an anti-angiogenic agent in neuroblastoma.
|
Cancer Lett
|
2003
|
0.80
|
|
72
|
Cross-talk between hematopoiesis and angiogenesis signaling pathways.
|
Curr Mol Med
|
2002
|
0.80
|
|
73
|
Inhibition of angiogenesis by β-galactosylceramidase deficiency in globoid cell leukodystrophy.
|
Brain
|
2013
|
0.79
|
|
74
|
Endocrine-like cells in the chick embryo thymus express ultrastructural features of piecemeal degranulation.
|
Anat Rec A Discov Mol Cell Evol Biol
|
2005
|
0.79
|
|
75
|
Erythropoietin is involved in angiogenesis in human primary melanoma.
|
Int J Exp Pathol
|
2010
|
0.79
|
|
76
|
Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma.
|
J Control Release
|
2013
|
0.78
|
|
77
|
In situ hybridization and immunogold localization of vascular endothelial growth factor receptor-2 on the pericytes of the chick chorioallantoic membrane.
|
Cytokine
|
2002
|
0.78
|
|
78
|
Mast cells and macrophages in duodenal mucosa of mice overexpressing erythropoietin.
|
J Anat
|
2009
|
0.78
|
|
79
|
B16-F10 melanoma cells contribute to the new formation of blood vessels in the chick embryo chorioallantoic membrane through vasculogenic mimicry.
|
Clin Exp Med
|
2012
|
0.78
|
|
80
|
Correlation between NGF/TrkA and microvascular density in human pterygium.
|
Int J Exp Pathol
|
2009
|
0.78
|
|
81
|
Angiogenic response induced by acellular femoral matrix in vivo.
|
J Anat
|
2005
|
0.78
|
|
82
|
Dense-core granules in neuroendocrine cells and neurons release their secretory constituents by piecemeal degranulation (review).
|
Int J Mol Med
|
2006
|
0.78
|
|
83
|
Ultrastructural evidence of a vesicle-mediated mode of cell degranulation in chicken chromaffin cells during the late phase of embryonic development.
|
J Anat
|
2009
|
0.77
|
|
84
|
A comparative study of the spatial distribution of mast cells and microvessels in the foetal, adult human thymus and thymoma.
|
Int J Exp Pathol
|
2009
|
0.77
|
|
85
|
Aquaporin-1 expression in the chick embryo chorioallantoic membrane.
|
Anat Rec
|
2002
|
0.77
|
|
86
|
Cell secretion mediated by granule-associated vesicle transport: a glimpse at evolution.
|
Anat Rec (Hoboken)
|
2010
|
0.77
|
|
87
|
Effects of prednisolone on the dystrophin-associated proteins in the blood-brain barrier and skeletal muscle of dystrophic mdx mice.
|
Lab Invest
|
2013
|
0.77
|
|
88
|
Differential expression of angiogenic and anti-angiogenic molecules in the chick embryo chorioallantoic membrane and selected organs during embryonic development.
|
Int J Dev Biol
|
2013
|
0.76
|
|
89
|
The development of the vascular system: a historical overview.
|
Methods Mol Biol
|
2015
|
0.76
|
|
90
|
Osteocalcin is angiogenic in vivo.
|
Cell Biol Int
|
2005
|
0.76
|
|
91
|
Tryptase- and leptin-positive mast cells correlate with vascular density in uterine leiomyomas.
|
Am J Obstet Gynecol
|
2007
|
0.76
|
|
92
|
In vitro and in vivo pro-angiogenic effects of thymosin-β4-derived peptides.
|
Cell Immunol
|
2011
|
0.76
|
|
93
|
Angiogenic activity of multiple myeloma endothelial cells in vivo in the chick embryo chorioallantoic membrane assay is associated to a down-regulation in the expression of endogenous endostatin.
|
J Cell Mol Med
|
2008
|
0.75
|
|
94
|
Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: an ultrastructural study.
|
Leuk Lymphoma
|
2002
|
0.75
|
|
95
|
Calbindin-D28K immunoreactivity in the human cerebellar cortex.
|
Anat Rec (Hoboken)
|
2014
|
0.75
|
|
96
|
Catecholamine release by chromaffin cells: a lesson from mast cells.
|
Gen Comp Endocrinol
|
2005
|
0.75
|
|
97
|
Cross talk between haematopoiesis and angiogenesis.
|
Adv Exp Med Biol
|
2003
|
0.75
|
|
98
|
Podoplanin and LYVE-1 expression in lymphatic vessels of human neuroblastoma.
|
J Neurooncol
|
2010
|
0.75
|
|
99
|
In vivo administered reserpine increases piecemeal degranulation in rat adrenal chromaffin cells.
|
Anat Rec A Discov Mol Cell Evol Biol
|
2006
|
0.75
|